Rigvir holding announces a grant programme

Rigvir holding announces a grant programme for the publications of clinical research, prospective or retrospetive, and case reports on oncolytic virotherapy.

A grant up to a maximum of 3000 EUR for publication in a Pubmed indexed journal and a grant up to a maximum of 1000 EUR for publication in a popular science journal. More information:
https://www.virotherapy.eu/doc/IVC_grants_EN.pdf

Contacts for Media Inquiries

Rigvir Group
Address: 9-7 Teatra street, LV–1050, Riga, Latvia
Phone: +371 67 229 599
E-mail: pr@rigvir.com